Global Pompe Disease Therapeutics Development Pipeline Review 2015 - Research and Markets

DUBLIN--()--Research and Markets (http://www.researchandmarkets.com/research/7zl56r/pompe_disease) has announced the addition of the "Pompe Disease - Pipeline Review, H2 2015" report to their offering.

This report provides comprehensive information on the therapeutic development for Pompe Disease, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Pompe Disease and special features on late-stage and discontinued projects.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Key Topics Covered:

  1. Introduction
  2. Pompe Disease Overview
  3. Therapeutics Development
  4. Pipeline Products for Pompe Disease - Overview
  5. Pipeline Products for Pompe Disease - Comparative Analysis
  6. Pompe Disease - Therapeutics under Development by Companies
  7. Pompe Disease - Therapeutics under Investigation by Universities/Institutes
  8. Pompe Disease - Pipeline Products Glance
  9. Late Stage Products
  10. Clinical Stage Products
  11. Early Stage Products
  12. Pompe Disease - Products under Development by Companies
  13. Pompe Disease - Products under Investigation by Universities/Institutes
  14. Pompe Disease - Companies Involved in Therapeutics Development
  • Alexion Pharmaceuticals, Inc.
  • Amicus Therapeutics, Inc.
  • Audentes Therapeutics, Inc.
  • BioMarin Pharmaceutical Inc.
  • Cortex Pharmaceuticals, Inc.
  • EpiVax, Inc.
  • Etubics Corporation
  • Genzyme Corporation
  • greenovation Biotech GmbH
  • Oxyrane Belgium NV
  • Pharming Group N.V.
  • Sarepta Therapeutics, Inc.

For more information visit http://www.researchandmarkets.com/research/7zl56r/pompe_disease

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Pharmaceuticals

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Pharmaceuticals